Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 19Active not recruiting 6Unknown 5Recruiting 4Withdrawn 3Terminated 3Enrolling by invitation 2Not yet recruiting 1

Sponsor Class

OTHER 4

Study Type

Observational 3Interventional 1

Sponsor

Cancer Type

Breast 3

Conditions

Cardiotoxicity 4Breast Neoplasms 3Ventricular Dysfunction 1Neoplasms 1Heart Failure 1

Interventions

pembrolizumab 567Specimen Handling 487Carboplatin 456Magnetic Resonance Spectroscopy 442Cyclophosphamide 418Cisplatin 412Radiotherapy 353Gemcitabine 318Bevacizumab 317Paclitaxel 304Biopsy 291Drug Therapy 286Blood Specimen Collection 249Capecitabine 244Oxaliplatin 242fludarabine 238Nivolumab 236venetoclax 227Injections 214Docetaxel 209Fluorouracil 204Dexamethasone 187Radiosurgery 182Rituximab 162Pemetrexed 160Standard of Care 156Surgical Procedures, Operative 148durvalumab 146atezolizumab 146tislelizumab 140

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Echocardiography × Clear all
NCT06023576 2026-05-14

A Study of Blood Pressure Control During Cancer Treatment

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
130 enrolled
Breast

Breast Neoplasms, Cardiotoxicity

NCT06664528 2025-03-04

CV_CANCER

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Recruiting
300 enrolled

Neoplasms, Cardiotoxicity

NCT05851053 2024-05-29

BLOC-II

University Medical Center Groningen

Recruiting
455 enrolled
Breast

Breast Neoplasms, Heart Failure, Ventricular Dysfunction, Cardiotoxicity

NCT06282796 2024-02-28

Early Prediction and Warning for Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy

First Hospital of China Medical University

Recruiting
600 enrolled
Breast

Breast Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡